Top Suppliers:I want be here

123171-59-5

123171-59-5 structure
123171-59-5 structure
  • Name: Cefepime Dihydrochloride Monohydrate
  • Chemical Name: cefepime hydrochloride
  • CAS Number: 123171-59-5
  • Molecular Formula: C19H28Cl2N6O6S2
  • Molecular Weight: 571.498
  • Catalog: API Antibiotics Cephalosporin
  • Create Date: 2018-07-10 10:37:43
  • Modify Date: 2026-06-30 16:48:15
  • Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.Target: AntibacterialCefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days [1]. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated [2].

Name cefepime hydrochloride
Synonyms Cefime dihydrochloridum monohydricum
Cefime Hydrocloride
Cefime dihydrochloride monohydrate, Antibiotic for Culture Media Use Only
Cefepime (Dihydrochloride Monohydrate)
Cefime hydrochloride //BP
Cefime (hydrochloride hydrate)
Cefime hydrochloride/Cefime hydrochloride
Cefepime hydrochloride
Cefime Dihydrochloride Monohydrate,Bacterial,Antibiotic,inhibit,Cefime Dihydrochloride,Inhibitor
123-5 Cefime hydrochloride
(6R,7R)-7-[(Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-[1-(1-methylpyrrolidinyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-cboxylic acid hydrochloride monohydrate
Pyrrolidinium, 1-[[7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, monohydrochloride, monohydrate, [6R-[6α,7β(Z)]]
1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(MethoxyiMino)acetyl]amino]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]Methyl]-1-MethylpyrrolidiniuM Inner Salt Dihydrochloride Monohydrate
Axim
Cefpixime Hydrochloride
CEFIME HCL
Cefime hydrochloride
Cefim dihydrochloride
Cefime 2HCl
7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-[(1-methyl-1-pyrrolidin-1-iumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-cboxylate hydrochloride
1-(((6R,7R)-7-((Z)-2-(2-Amino-thiazol-4-yl)-2-(methoxyimino)-acetcboxcboxcboxamido)-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidin-1-ium chloride HCl hydrate
Cefepime chloride hydrochloride hydrate
cefepime dihydrochloride monohydrate
CefiMe dihydrochloride hydrate
Cefime hydrochlorider
MFCD06804606
Cefime Dihydrochloride Monohydrat
pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, inner salt, hydrochloride, hydrate (1:2:1)
Cefime dihydrochloride monohydrate for system suitability CRS
(6R-(6a,7b(Z)))-1-((7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidinium Chloride Monohydrochloride Monohydrate
Cefime dihydrochloride monohydrate CRS
1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl- pyrrolidinium Inner Salt Hydrochloride Monohydrate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate dihydrochloride hydrate
Cefime dihydrochloride salt monohydrate
Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, monohydrochloride, monohydrate
Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride, hydrochloride, hydrate (1:1:1:1)
PyrrolidiniuM,1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(MethoxyiMino)acetyl]amino]-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]Methyl]-1-Methyl-,chloride, hydrochloride, hydrate (1:1:1:1)
Maxipime
Axepim
1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidinium Chloride 72-(Z)-(O-Methyloxime) Monohydrochloride Monohydrate
Cefime Hydrochloride Monohydrate
Cefime HydrochlorideQ: What is Cefime Hydrochloride Q: What is the CAS Number of Cefime Hydrochloride Q: What is the storage condition of Cefime Hydrochloride Q: What e the applications of Cefime Hydrochloride
(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium chloride, 7(sup 2)-(Z)-(O-methyloxime), monohydrochloride, monohydrate
Cefime Dihydrochloride(sterile)
Cefime 2HCl monohydrate
Cefime Dihydrochloride RS
Cefime dihydrochloride monohydrate for system suitability (Y0000634)
1-{[(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidinium chloride hydrochloride hydrate (1:1:1:1)
1-(((6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-cboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-methylpyrrolidin-1-ium chloride hydrochloride hydrate
Cefime hydrochloride,NA
Cefime Hydrochloride G0D116860ug/mg(an)
Cefime Dihydrochloride Monohydrate, 10 mM in DMSO
Cimex
efime hydrochloride
Cefime Hydrochloride Crude
CEFIME HYDROCHLORIDE (BUFFERED WITH GININE)
Description Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.Target: AntibacterialCefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days [1]. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated [2].
Related Catalog
References

[1]. Neu, H.C., Safety of cefepime: a new extended-spectrum parenteral cephalosporin. Am J Med, 1996. 100(6A): p. 68S-75S.

[2]. Wynd, M.A. and J.A. Paladino, Cefepime: a fourth-generation parenteral cephalosporin. Ann Pharmacother, 1996. 30(12): p. 1414-24.

Melting Point 150ºC(dec.)
Molecular Formula C19H28Cl2N6O6S2
Molecular Weight 571.498
Exact Mass 570.088867
PSA 212.81000
LogP 1.12860
Storage condition Store at 0-5°C
Hazard Codes Xi
Risk Phrases R36/37/38
Safety Phrases 22-26-36/37/39
RIDADR NONH for all modes of transport
HS Code 29419000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.